Physician profile
Christopher Wong
NPI 1457529174
$3,003.87
in general payments reported to CMS, 2019-2025
14 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.84 · 2020: $1,112 · 2021: $469 · 2022: $401 · 2023: $510 · 2024: $335 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $668 · Education: $287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $668.15 |
| Education | $286.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $807.91 | 2020-2022 | |
| Boston Scientific Corporation | $552.38 | 2022-2023 | Emblem Mri S-Icd, Accolade Sr |
| Abbott Laboratories | $539.03 | 2021-2022 | |
| Glaxosmithkline, LLC. | $313.53 | 2023-2025 | Trelegy Ellipta |
| Amarin Pharma, INC. | $299.29 | 2020 | |
| Abiomed | $137.93 | 2024 | Impella |
| Amgen INC. | $101.39 | 2019-2021 | |
| Medtronic, INC. | $83.85 | 2021 | |
| Coherus Oncology, INC. | $72.94 | 2021 | |
| Pfizer INC. | $28.89 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $18.93 | 2024 | |
| Biosense Webster, INC. | $17.42 | 2023 | Carto 3 |
| Viiv Healthcare Company | $17.36 | 2023 | Apretude |
| Abbvie INC. | $13.02 | 2023 | Qulipta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.